WuXi Biologics is trading 4.77% up now at $52.75 after announcing the cancellation of 39.8245 million repurchased shares.

  • The cancellation was announced on September 18, 2026, representing 0.95826% of issued shares.
  • It reduced the outstanding share count and potentially improved per-share value.
  • The company-specific announcement was the clearest catalyst identified for the September 21 move, with broader market conditions providing a supportive backdrop.